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Abstract 
The almost forgotten crop amaranth has gained renewed interest in recent years due 
to its immense nutritive potential. Health beneficial effects of certain plants are often 
attributed to secondary plant metabolites such as phenolic compounds. As these 
compounds undergo significant metabolism after consumption and are in most cases 
not absorbed very well, it is important to gain knowledge about absorption, 
biotransformation, and further metabolism in the human body.  
Whilst being hardly found in other edible plants, caffeoylisocitric acid represents the 
most abundant low molecular phenolic compound in many leafy amaranth species. 
Given that this may be a potentially bioactive compound, gastrointestinal microbial 
degradation of this substance was investigated in the present study by performing in 
vitro fermentation tests using three different fecal samples as inocula. The (phenolic) 
metabolites were analyzed using high-performance liquid 
chromatography/electrospray ionization tandem mass spectrometry (HPLC-ESI-
MS/MS). Furthermore, quantitative polymerase chain reaction (qPCR) analyses were 
carried out to study the influence on the microbiome and its composition. The in vitro 
fermentations led to different metabolite profiles depending on the specific donor. For 
example, the metabolite 3-(4-hydroxyphenyl)propionic acid was observed in one 
fermentation as the main metabolite, whereas 3-(3-hydroxyphenyl)propionic acid was 
identified in the other fermentations as important. A significant change in selected 
microorganisms of the gut microbiota however was not detected. 
In conclusion, caffeoylisocitric acid from amaranth ,which is a source of several 
esterified phenolic acids in addition to chlorogenic acid, can be metabolized by the 
human gut microbiota, but the metabolites produced vary between individuals. 
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1. Introduction1 
Amaranth (Amaranthus sp.) can be used either as a grain, a leafy vegetable, or as an 
ornamental plant (Zehring et al., 2015). It was an important staple food of the New 
World in pre-Columbian times but it fell into disuse during the Spanish conquest and 
was afterwards largely neglected (Council, 1984). However, as an inexpensive 
source of a diverse variety of compounds with several health benefits and a 
corresponding high nutritive potential, interest in amaranth as a food source has 
notably increased again, especially in developing countries in Eastern Africa 
(Prakash & Pal, 1991; Shukla, Bhargava, Chatterjee, Pandey, & Mishra, 2010). As a 
result, amaranth is currently regarded as a third millennium crop plant (Rastogi & 
Shukla, 2013).  
Amaranth is a member of the Amaranthaceace family with more than 60 species 
worldwide (Council, 1984). Whilst in Europe and America the grains or seeds of 
amaranth are considered as pseudo-cereals, in parts of Africa and Asia the leaves 
are mainly consumed as vegetables (Das, 2016). In some studies, antioxidant, 
                                                          
1 CA, caffeic acid; C-IA caffeoylisocitric acid; C-QA chlorogenic acid; 3,4-DHPPA, 3-(3,4-
dihydroxyphenyl)propionic acid; high-performance liquid chromatography/electrospray 
ionization tandem mass spectrometry, (HPLC-ESI-MS/MS); 3-HPPA; 3-(3-
hydroxyphenyl)propionic acid; 4-HPPA, 3-(4-hydroxyphenyl)propionic acid; 3-PPA, 3-
phenylpropionic acid; quantitative polymerase chain reaction, qPCR. 
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antimalarial, and even antiviral properties of amaranth are described, but the 
identification of the compounds responsible for such properties is still lacking (Das, 
2016; Neugart, Baldermann, Ngwene, Wesonga, & Schreiner, 2017; Shukla et al., 
2010; Zehring et al., 2015). Similar to many other promising food and pharmaceutical 
plants, positive nutritional characteristics are often attributed to bioactive compounds 
such as secondary plant metabolites (Das, 2016). 
One of the major groups of these secondary plant metabolites are phenolic 
compounds. They are characterized by an aromatic ring with one or more hydroxyl 
groups (Robbins, 2003). From the very large group of phenolic compounds, phenolic 
acids are in general phenols which contain a carboxylic acid function. Plant phenolic 
acids are divided into two groups: hydroxycinnamic acids and hydroxybenzoic acids 
(Robbins, 2003). In most plants, hydroxycinnamic acids are additionally esterified to 
sugars, organic acids, or lipids to alter their solubility in cell organelles such as in the 
vacuole (Clifford, 1999; Marin, Miguelez, Villar, & Lombo, 2015). The most prominent 
conjugated phenolic acid described is chlorogenic acid (3-O-caffeoylquinic acid, C-
QA) which is essentially ubiquitous in the plant kingdom (Figure 1A) (Clifford, 1999; 
Khanam, Oba, Yanase, & Murakami, 2012). A multitude of biological effects has 
been assigned to C-QA as reviewed by Clifford (1999) turning it into a popular 
compound often claimed as a health promoting agent. C-QA derivatives have been 
postulated to be protective against, for example, cardiovascular diseases, type 2 
diabetes, and to act as modulator of chemopreventive phase II-enzymes via the 
Nrf2/ARE pathway (Boettler et al., 2011; Mills et al., 2015). However, C-QA may also 
have adverse effects, as it may be responsible for stimulating gastric acid secretion 
causing gastric irritations (Weiss et al., 2010). 
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In comparison with coffee which is already well characterized, only a few further non-
esterified phenolic acids such as vanilic acid, gallic acid, caffeic acid, p-coumaric 
acid, ferulic acid, and m-coumaric acid have been described in amaranth thus far 
(Khanam et al., 2012). The identification of hydroxycinnamic acid esters from the 
cotyledons of Amaranthus cruentus was described in the late 1980s, but detailed 
knowledge about the phenolic compound composition is still limited (Alvarez-Jubete, 
Wijngaard, Arendt, & Gallagher, 2010; Strack, Leicht, Bokern, Wray, & Grotjahn, 
1987). A new study on the quantification of esterified phenolic acids in amaranth, 
depending on genotype, has shown that two isomers of caffeoylisocitric acids (C-IA, 
Figure 1 B), and various caffeoylaldaric acids are the main esterified phenolic acids 
present, as determined in the leaves of 14 different amaranth genotypes tested. 
Furthermore, feruloylisocitric acids, feruloylaldaric acids, and coumaroylaldaric acids 
were also present in minor concentrations (Schröter et al., 2017). In the study by 
Schröter et al. (2017) it has also been shown that the concentration of C-IA is 
different depending on the amaranth species. For example, the highest concentration 
were found in A. hybridus cv. IP-7 had with 19.39 ± 1.00 mg∙g-1 dry weight, whereas 
the concentration in other species such as A. tricolor cv. Arkasugna are with 0.66 ± 
0.16 mg∙g-1 dry weight much lower. However, such phenolic acid derivatives are 
considered quite ‘exotic’ and their potential for being bioactive with regard to 
nutritional physiology is not yet defined. Nevertheless, when claiming bioactivity for a 
certain secondary plant metabolite, it is necessary to obtain information about the 
absorption, distribution, and biotransformation of these compounds in humans. For 
phenolic compounds there are several factors that influence the uptake of a 
substance which was already shown for the prominent and structurally similar C-QA 
(e.g. Genothier, Verny, Besson, Remesy, and Scalbert, 2003). 
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The degradation by the colonic microbiota plays an important role, as re-absorption 
rates of phenolic compounds might differ very drastically depending on their chemical 
structure (Scalbert & Williamson, 2000). While free phenolic acids such as caffeic 
acid (CA, chemical structure see Figure 6) are nearly completely absorbed in the 
small intestine, measurements of the recovery of C-QA in ileostomy effluents showed 
that only 30% of C-QA is taken up by passive diffusion (Manach, Williamson, 
Morand, Scalbert, & Remesy, 2005; Tomas-Barberan et al., 2014). This is related to 
the fact that C-QA is more hydrophilic than CA and there are no specific esterases 
that are able to hydrolyze the ester bonds (Marin et al., 2015). Instead, C-QA reaches 
the colon and undergoes degradation by the gut microbiota (Ludwig, de Pena, Cid, & 
Crozier, 2013; Tomas-Barberan et al., 2014). So far, researchers focused on the 
investigation of C-QA derivatives, as they are consumed worldwide in terms of 
products, such as coffee, apples, and potatoes (Manach, Scalbert, Morand, Remesy, 
& Jimenez, 2004). In vitro studies on the microbial conversion of C-QA presented a 
rapid degradation of the substrate within the first few hours and metabolites formed, 
such as 3-(3,4-dihydroxyphenyl)propionic acid, 3-(3-hydroxyphenyl)propionic acid 
and benzoic acid (Gonthier et al., 2006; Rechner et al., 2004). Due to the inter-
individual microbiota composition of each person, the transformation of plant 
phenolics may be extremely different. As a result of the polyphenol – bacteria 
interaction, phenolic compounds may affect the host health positively by promoting 
beneficial and inhibiting potentially pathogenic bacteria (Braune & Blaut, 2016; 
Duenas et al., 2015). 
With regard to the different phenolic acid derivatives and their specific 
physicochemical properties such as polarity, solubility, molecular size, and 
conformation, caffeoylisocitric acid might differ tremendously from C-QA suggesting a 
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different behavior in the human gastrointestinal tract. With regard to amaranth it is of 
interest to determine whether or not the nutritive potential of amaranth arises from 
those exotic phenolic acid esters such as C-IA and/or their biotransformation. 
The aim of the present study was to determine the in vitro degradation of C-IA and C-
QA with fecal microbiota from three different donors to investigate the 
biotransformation of C-IA by the human gut microbiota. Furthermore, qPCR analyses 
were performed to determine the initial composition of the microbiota and a possible 
change during the fermentations. 
 
2. Material and Methods 
2.1 Extraction and purification of caffeoylisocitric acid 
The isolation of caffeoylisocitric acid (C-IA) was carried out following the protocol 
described by Schröter et al. (2017). Briefly, 8 mL of 60% methanol were added to 500 
mg amaranth (dry matter) and the compounds were extracted under continuous 
shaking for 30 min at room temperature. Afterwards, the mixture was centrifuged for 
5 min at 990  g at 21 °C. The supernatants were collected and the solvent was 
removed on a rotary evaporator. The solutions were cleaned-up by solid phase 
extraction (SPE). The SPE fractions were collected, concentrated with a rotary 
evaporator and then used for semi preparative liquid chromatography analysis. The 
fractions of the different semi preparative analysis which contained the C-IA were 
combined and the organic solvent was removed on a rotary evaporator. Finally, the 
aqueous solution was lyophilized. From the extract of 1 g freeze dried amaranth 
powder an amount of approx. 10 mg C-IA was obtained. The purity of the isolated C-
IA was assessed by HPLC-DAD-ESI-MS. The amount of C-IA was estimated from 
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the LC-UV signal at 320 nm based on the assumption that C-IA has a similar 
molecular extinction due to the fact that CA is the only UV-active part of the molecule 
C-IA. The purity of the C-IA was 91% (HPLC-DAD, 320 nm). The contamination 
results from another isomer of C-IA. Moreover, no other contaminants were detected 
neither by HPLC-DAD nor -ESI-MS detection. The identity of C-IA was assessed 
following the chromatographic and mass spectrometric parameters as described by 
previous work (Schröter et al., 2017). 
2.2 Preparation of the fecal suspension 
Aliquots of 0.5 g of fresh fecal sample from three different, healthy donors (donor A, 
B, and C) were mixed with 12 mL of pre-reduced phosphate buffered saline and 
homogenized in a Dispomix Drive (Medic Tools AG, Lussiwag, Switzerland). Each of 
the fecal suspensions was then used as an inoculum for one of the three in vitro 
fermentations. All three donors did not suffer from gastrointestinal disorders and did 
not receive any antibiotics within three months prior to donation. 
2.3 Fermentation medium 
The medium used here contains a range of minerals, vitamins, supplements and 
carbon sources to enable a wide range of gut bacteria to grow. It has been used in 
fermentor experiments of the human microbiota (e.g. Walker, Duncan, Leitch, Child, 
and Flint, 2005) and seems to sustain a diverse microbiota composition. The 
composition of the fermentation medium per liter distilled water was as follows: 4.5 g 
NaCl, 3.2 g NaHCO3, 2 g K2HPO4, 1 g casein hydrolysate, 1 g yeast extract, 1 g 
potato starch, 0.5 g MgSO4  7 H2O, 0.45 g CaCl2  2 H2O, 0.25 g xylan from oat 
spelts, 0.25 g pectin from apple, 0.25 g amylopectin from potato, 0.25 g 
arabinogalactan from larch wood, 0.005 g FeSO4  7 H2O, 0.01 g haemin, 0.05 g bile 
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salts, 0.6 ml resazurin (0.1%), 2 mL mineral solution (500 mg EDTA, 200 mg FeSO4 
 7 H2O, 30 mg H3BO3, 20 mg CoCl2  6 H2O, 10 mg ZnSO4  7 H2O, 7.5 mg 
NaSeO3, 3 mg MnCl2  7 H2O, 3 mg NaMoO4  2 H2O, 2 mg NiCl2 6 H2O, 1 mg CuCl2 
 2 H2O per liter), 3.6 mL volatile fatty acid (VFA) solution (17 mL acetic acid, 1 mL n-
valeric acid, 1 mL iso-valeric acid, 1 mL iso-butyric acid neutralized with 20 mL 10 M 
NaOH), and 0.5 g cysteine HCl. The fermentation medium was boiled for 1 min while 
flushing with CO2 and aliquots were dispensed into Hungate tubes with butyl rubber 
stoppers and screw caps under a CO2 atmosphere (Bellco Glass, Shrewsbury, UK). 
Finally the Hungate tubes were autoclaved. 
2.4 In vitro fermentations with fecal sample microbiota 
Three independent in vitro fermentations (fermentation A, B and C) with the 
substrates C-IA and C-QA as a reference were carried out at an initial pH value of 6.5 
with a final volume of 10 mL. As the pH could not be controlled, it is estimated that 
the pH dropps by 0.5-1 units during fermentation based on previous experiments with 
similar levels of carbon source present. Immediately before the incubation of the 
fermentation media with the fecal suspension was performed, 100 µL of the substrate 
C-QA or C-IA (final concentration 200 µM, pre-dissolved in DMSO) and 14 µL vitamin 
solution (10 g nicotinamide, 5 g p-aminobenzioc acid, 4 g thiamine, 2 g biotin, 2 g 
pantothenate, 1 g menadione, 0.5 g cobalamine per liter; filter-sterilised) were added 
to 9.4 mL of the fermentation medium while flushing with CO2. Subsequently, 0.5 mL 
freshly prepared fecal suspension were added (0.2 % final fecal concentration) and 
were incubated for 48 h on a rotator (Stuart SB3, Bibby Scientific, Stone, UK) at 37 
°C and 25 rpm. Initially (0 h) and after 3 h, 7 h, 24 h, and 48 h, two aliquots of 0.75 
mL each were taken from the fermentation mixtures under a CO2 atmosphere. The 
first aliquot was frozen with liquid nitrogen and stored at -80 °C until HPLC-ESI-
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MS/MS analysis. The second aliquot was centrifuged for 10 min at 10,000  g at 4 °C 
(Jouan MR 18.22, Sartorius AG, Göttingen, Germany). For DNA extractions and 
qPCR analysis, only the pellets from the 48 h samples and 400 µL of the fecal 
suspension from every donor (see 2.2) were used. The latter’s were taken to 
determine the initial microbiota of each donor. Samples were immediately re-
suspended in 122 µL MT buffer followed by adding 800 µL sodium phosphate buffer 
and transferred to Lysing Matrix E tubes (solutions and tubes are used from the 
FastDNA® spin kit for soil, MP Biomedicals, Illkirch, France). Storage was at -80 °C. 
Residual pellets were stored as a backup at -80 °C without buffer treatment. 
Every fermentation was conducted in triplicate except the first fermentation of C-QA 
which was done in duplicate as one incubation failed. Negative control incubations 
without the addition of C-QA or C-IA were done for every fermentation in triplicate. 
For that, 100 µL DMSO were added instead of the substrate (‘control samples I). The 
no-substrate controls were performed in order to estimate the metabolite formation 
out of the phenolic substances  being naturally present in the fecal samples. This is 
related to the fact that the donors might have consumed food the day before which 
also contained phenolic acids.  
Furthermore, to estimate the interactions between the medium and the substrates, 
aliquots of 9.9 mL medium were filled into Hungate tubes and mixed with 100 µL of 
C-QA or C-IA and 14 µL vitamin solution (‘control samples II’). 
 
2.5 Extraction of chlorogenic acid, caffeoylisocitric acid and its metabolites 
400 µL fermentation mixture were mixed with 15 µL of ascorbic acid solution (20 % in 
water) for adjusting the pH and as a protector against autoxidation. Afterwards, the 
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samples were centrifuged for 10 min at 18,000  g and 4 °C and the supernatants 
were transferred into a tube. To extract all compounds (remaining substrates and 
metabolites), 350 µL ethyl acetate were added to the supernatants and pellets, 
respectively and vortexed. As all substances are of different polarity, the ethyl acetate 
extraction used in this study was a compromise. However,  previous studies have 
shown its appropriateness (own results, data not shown). 
The ethyl acetate phases were combined. The pellets were discarded and the 
extractions were carried out twice again with the supernatants and 350 µL ethyl 
acetate as described above. The ethyl acetate phases were collected. All combined 
ethyl acetate phases were dried under a gaseous stream of nitrogen, residues 
dissolved in 400 µL methanol/water (1:1, v/v), and vortexed for 20 seconds. Finally, 
the samples were centrifuged at 18,000  g and 4 °C for 10 min and 50 µL were 
transferred into a vial for HPLC-ESI-MS/MS analysis. 
2.6 HPLC-ESI-MS/MS analysis 
HPLC analyses were done using a 1260 Agilent Series system consisting of a binary 
pump, an online-degasser, an autosampler, and a column oven. The separation of all 
substances was carried out on an Ascentis® Express F5 column, 15 cm  3 mm, 5 
µm equipped with an Ascentis® Express F5, 5 cm  3 mm, 2.7 µm pre-column (both 
from Sigma Aldrich Chemie GmbH, Taufkirchen, Germany) at 40 °C. For the 
chromatographic analysis, a binary gradient system (eluent A: 0.1% formic acid in 
water, eluent B: acetonitrile) was used as follows with a flow rate of 0.65 mL/min: 2% 
B at 0 - 1.5 min, 50% B at 15 min, 90% B at 15.1 - 20 min, 2% B at 20.1 - 25 min. 
The injection volume was 5 µL.  
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MS analyses were performed in negative ion mode using a QTrap 6500 triple 
quadrupole mass spectrometer (AB Sciex Germany GmbH, Darmstadt, Germany) 
equipped with an ESI interface. The electrospray voltage was set at -4500 V and the 
temperature at 450 °C. Nitrogen was used for the curtain gas (3.5 bar), ion source 
gas 1 (3.5 bar), ion source gas 2 (4.1 bar), and collision gas. For each substance, the 
optimal declustering potential, entrance potential, collisions energy, collision exit 
potential, and characteristic fragments were determined. The fragment with the 
highest intensity was used for quantification. The fragments with lower intensity were 
used as qualifiers. The method included the following substances: C-QA, C-IA, 
caffeic acid (CA), benzoic acid, 3-(3,4-dihydroxyphenyl)propionic acid (3,4-DHPPA), 
3-(3-hydroxyphenyl)propionic acid (3-HPPA), 3-(4-hydroxyphenyl)propionic acid (4-
HPPA), 3-phenylpropionic acid (3-PPA), p-coumaric acid, 3,4-dihydroxybenzoic acid, 
3-(3,4-dihydroxyphenyl)acetic acid, hippuric acid, methylhippuric acid, and 
phenylacetic acid. For quantification, an external calibration was used. The data were 
generated and analyzed with the software Analyst® 1.6.2 from AB Sciex Germany 
GmbH (Darmstadt, Germany). 
2.7 DNA extractions 
DNA extractions from the fecal slurries and from the aliquots of the fermentations 
mixtures were carried out for further qPCR analyses. The DNA was extracted with 
the FastDNA® spin kit for soil (MP Biomedicals, Illkirch, France), using 400 µL of the 
fecal inoculum and the cell pellets from the 48 h samples, which were already re-
suspended in buffer. The DNA extracts were stored at -80 °C until qPCR analysis. 
2.8 Fluorimetric DNA quantification and qPCR analysis 
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DNA was quantified using a Qubit dsDNA BR Assay kit on a QubitTM 3.0 Fluorimeter 
(Thermo Fisher Scientific, Renfrew, UK) as per manufacturer’s instructions. 
Quantitative real-time PCR (qPCR) was performed in duplicate with iTaqTM Universal 
SYBR® Green Supermix (Bio-Rad) in a total volume of 10 μl in the presence of 1 
µg/ml herring sperm DNA with primers at 500 nM and 2 ng of DNA in optical-grade 
384-well plates sealed with optical sealing tape. Amplification was performed with a 
CFX384TM Real-time System (Bio-Rad) with the following protocol: one cycle of 95 ºC 
for 3 min, 40 cycles of 95 ºC for 5 s and annealing temperature as per Table 1 for 30 
s, 1 cycle of 95 ºC for 10 s and a stepwise increase of the temperature from 65 ºC to 
95 ºC (at 5 s per 0.5 ºC) to obtain melt curve data. As described previously (Ramirez-
Farias et al., 2009) standard curves consisted of dilution series of amplified bacterial 
16S rRNA genes from reference strains. Samples were amplified with universal 
primers against total bacteria and specific primers against Bifidobacterium spp., 
Bacteroidetes, Ruminococcaceae, Lachnospiraceae, F. prausnitzii, Blautia spp., and 
the Roseburia/Eubacterium rectale group (Table 1).  
2.9 Statistical analysis of the qPCR results 
To determine a possible change in the microbiota caused by either C-QA or C-IA, 
statistical analysis was performed. Data were analyzed with IBM SPSS Statistics 22 
(Ehningen, Germany). For every donor, the data for the ‘control samples I’, C-QA, 
and C-IA out of the triplicate fermentations were examined for normality. The 
normally distributed data were then investigated for significant differences between 
the ‘control samples I’ and either C-QA or C-IA with an independent t-test. A 
confidence level of 99% (p < 0.01) was defined as significant. 
3. Results 
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3.1 Analysis of caffeoylisocitric acid 
Caffeoylisocitric acid (C-IA) was extracted from amaranth and enriched with a solid 
phase extraction approach. Afterwards, further isolation was carried out by semi-
preparative HPLC with diode array detection. To confirm the successful isolation and 
purity of C-IA, mass spectrometric analyses were done by determining the exact 
mass of the molecular ion as well as the characteristic fragments. C-IA has a nominal 
mass of 354 atomic mass unit (amu). For the isolated substance, an m/z of 
353.05008 (error = 3.8 ppm) was determined, which represents the monoisotopic 
pseudomolecular ion [M-H]-. Furthermore, characteristic fragments with m/z values 
191.01891 (error = 4.3 ppm), 173.00835 (error = 4.7 ppm), 154.99740 (error = 7.7 
ppm) and 111.00813 (error = 5.7 ppm) were recorded (Figure 2). The first fragments 
occur from the fragmentation at the ester bond. The m/z 191.01891 results from the 
ios-citric acid after the loss of the CA followed by the loss of H2O resulting in a m/z 
value of 173.00835. The last two dominant signals can be assigned to fragments 
resulting from subsequent neutral losses of H2O and CO2. In general, the qTOF 
measurements confirmed the successful isolation of C-IA. 
3.2 In vitro fermentation of chlorogenic acid 
In all in vitro fermentations, C-QA was metabolized significantly by the fecal 
microbiota. The degradation and metabolite formation within the in vitro fermentations 
of C-QA are presented in Figure 3. The results represent the mean and the standard 
deviation of three independent incubations per donor. 
Within the first 7 h after the inoculation of the fermentation media with the fecal slurry 
from donor A (‘fermentation A’), an increase of caffeic acid (CA) was detected 
(Figure 3A). While CA was subsequently totally degraded by the microbiota between 
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7 h and 24 h, a simultaneous increase in the concentration of 3-(3,4-
dihydroxyphenyl)propionic acid (3,4-DHPPA, chemical structure see Figure 6) was 
recorded. 3,4-DHPPA reached its concentration maximum after 24 h. Transformation 
to 3-(4-hydroxyphenyl)propionic acid (4-HPPA, chemical structure see Figure 6) was 
detected between 24 h and 48 h.  
In contrast to the in vitro fermentation of C-QA with the fecal sample of donor A, a 
different metabolite profile was identified for the in vitro fermentation with the fecal 
samples from donor B (‘fermentation B’). Intermediary CA, was not detected. Instead, 
the concentration of the metabolite 3,4-DHPPA, as well as the concentration of the 
metabolite 3-(3-hydroxyphenyl)propionic acid (3-HPPA, chemical structure see 
Figure 6) increased within the first seven hours (Figure 3B). 3,4-DHPPA was then 
further degraded to 3-HPPA and was not detectable after 24 h. The concentration of 
3-HPPA increased to 50 µM within 24 h and remained nearly constant for the 
subsequent 24 hours.  
The metabolite profile from the degradation of C-QA during the early stage of 
fermentation with the fecal samples C (‘fermentation C’) was quite similar to 
fermentation with the fecal sample B (Figure 3C). An increase of the concentration of 
the metabolites 3,4-DHPPA and 3-HPPA was identified within the first 7 h. At this 
point, the concentration of 3-HPPA was lower than the concentration of 3,4-DHPPA 
whilst the concentration of 3-HPPA remained nearly constant up to 48 h. For 3,4-
DHPPA, a small decrease at 24 h, and a nearly constant concentration during the 
time period to 48 h was identified. However, the concentration of the latter was 
always higher than the concentration of 3-HPPA. 
In all three fermentations, a nearly constant level of the metabolite 3-phenylpropionic 
acid (3-PPA, chemical structure see Figure 6) was detected over the whole 
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fermentation period. When taking the results of the ‘control samples II’ (substrate and 
medium) additionally into consideration, the presence of 3-PPA probably arises from 
the interaction of the substrate with the medium, as the same amounts were 
identified in the ‘control samples II’ (data not shown). 
3.3 In vitro fermentation of caffeoylisocitric acid 
As well as in the fermentations with C-QA, the fecal microbiota from of all three 
donors was able to metabolize C-IA. Figure 4 displays the degradation and 
metabolite formation within the in vitro fermentations of C-IA. 
In the fermentation with the fecal sample from donor A, metabolite formation within 
the first 7 h was not detected (Figure 4A). Only small amounts of CA were formed. 
Between 7 h and 48 h, microbial transformation was apparent, resulting in the 
formation of the metabolite 3,4-DHPPA to at least 30 µM at 48 h. At the same time, 
the metabolite 4-HPPA was detected in small amounts.  
In fermentation with the fecal sample from donor B, the maximum concentration of 
3,4-DHPPA was reached after 7 h. At 24h the metabolite 3,4-DHPPA was totally 
metabolized and was not detected anymore(Figure 4B). Continuous formation of 3-
HPPA was registered from 3 h to 48 h.  
In fermentation C, the concentrations of 3,4-DHPPA and 3-HPPA increased within 
the first 7 h (Figure 4C). Between 7 h and 48 h, a further slight increase in the 
formation of 3-HPPA was detected, while the concentration of 3,4-DHPPA fell to a 
certain extent and remained essentially constant. 
As already presented for the fermentation of C-QA, the concentration of 3-PPA in the 
fermentations with C-IA was nearly constant (data not shown). In contrast to the 
fermentation with C-QA, the initial level was much higher (100 µM). Furthermore, the 
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concentration of 3-PPA was similar to the concentration in the ‘control samples II’ 
(substrate + medium) in all fermentations. Therefore, the metabolite 3-PPA is not 
shown in Figure 4. 
3.4 Fluorimetric DNA quantification and qPCR analysis 
To investigate whether the presence of the substrates influenced microbiota 
composition, qPCR was carried out against major bacterial groups. This included 
total bacteria, Bacteroidetes, Ruminococcaceae (Firmicutes), Lachnospiraceae 
(Firmicutes) and Bifidobacterium spp. (Actinobacteria), as well as some dominant 
genera within the Ruminococcaceae (Faecalibacterium prausnitzii) and 
Lachnospiraceae (Roseburia spp. & Eubacterium rectale as well as Blautia spp.). All 
data showed normal distribution. No significant changes (p < 0.01) between the 
‘control samples I’ and C-QA or C-IA after 48 h of incubation were found for any of 
the bacterial groups analyzed here (Figure 5). 
 
4. Discussion 
In the present work, in vitro fermentations with human fecal microbiota were 
performed in order to estimate the microbial metabolism of C-IA in comparison to the 
well-known phenolic acid derivative C-QA. While C-QA is present in a wide range of 
plants e.g., coffee, C-IA is one of the major phenolic acids in amaranth. Because of 
the different chemical nature of the esterification, it is of interest to determine if the 
gut microbiota can also convert C-IA to more lipophilic metabolites which can then be 
absorbed via the colon.  
The major end products of all fermentations were the metabolites 3,4-DHPPA and 
either 3-HPPA or, 4-HPPA, which is in accordance with in vitro fermentations of C-
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QA described in the literature (Gonthier et al., 2006; Rechner et al., 2004; Tomas-
Barberan et al., 2014). In general, the microbial degradation of C-QA showed the 
same metabolites as the degradation of C-IA within the same donor. As a first step, 
the substrate is degraded to CA, which is attributed to the cleavage of the ester bond. 
Furthermore CA is converted to 3,4-DHPPA, corresponding to the reduction of the 
double bond. Either 4-HPPA or 3-HPPA were then formed out of 3,4-DHPPA 
resulting from the dehydroxylation at the C3- or C4-position of the phenolic ring 
(Figure 6). The citrate liberated during biotransformation of C-IA cannot be detected 
with the used method but may be utilized by some other members of the microbiota, 
as has been demonstrated for lactic acid bacteria and Clostridium indolis (Biddle et 
al., 2014; Martino, Quintana, Espariz, Blancato, & Magni, 2016). 
Interestingly, fermentation with the microbiota from donor A lead to the formation of 
the metabolite 4-HPPA, whilst fermentation by the microbiota from donors B and C 
resulted in the formation of the metabolite 3-HPPA which likely reflects differences in 
the prevailing metabolic pathways in different donors. The two metabolites are 
generated by dehydroxylation of the aromatic ring in different positions. Chesson et 
al. (1999) reported that dehydroxylation at C4-position, resulting in 3-HPPA, is the 
major metabolite deriving from ferulic acid and CA, whereas dehydroxylation at the 
C3-position, leading to 4-HPPA, is rarely found. When taking the results of the 
present study into account, it is also recognized that the concentration of 4-HPPA in 
the fermentations of C-QA and C-IA (present in donor A) is notably lower than the 
concentration of 3-HPPA found in the fermentations with donors B and C. 
Furthermore, the early metabolite CA was only detected in fermentation with the fecal 
sample from donor A. This is in agreement with differences in the time courses of 
metabolite formation during the fermentations. 
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For C-QA as well as for C-IA, the rate of the metabolite formation increased in the 
order of fermentations A < C < B. For example, while in fermentation A 3,4-DHPPA 
was first detected after 24 h for both substrates, the metabolite was already present 
at its highest concentration after 7 h in fermentation B and C, and 3-HPPA was also 
present. For fermentation B the metabolite was then completely metabolized until 24 
h alongside further accumulation of 3-HPPA, whereas in fermentation C, both 3,4-
DHPPA and, at a lower concentration, 3-HPPA were still detected after 48 h. 
In general, the substrate degradation, metabolite formation and the time courses of 
C-QA and C-IA within a donor are very similar. Looking at the fermentations with the 
fecal slurry from donor A (Figure 3A and Figure 4A), the same metabolites (CA, 3,4-
DHPPA, 4-HPPA)  were detected at the same time points. In contrast to the 
fermentation of C-QA, where the concentration of 3,4-DHPPA acid had its maximum 
at 24 h, there is still a further increase of its concentration between 24 h and 48 h 
when fermenting C-IA. For fermentation B, the same metabolites at the same time 
points were also present in the fermentation of C-QA and C-IA, but the concentration 
of 3-HPPA was already higher at 7 h in the C-QA fermentation than the concentration 
of 3,4-DHPPA. The in vitro fermentation of C-IA with the fecal slurry from donor C 
showed very similar behavior in metabolite formation as in the one of C-QA. 
The determination of 3-PPA in every fermentation and control samples at the same 
concentration level leads to the conclusion that 3-PPA is not a microbial product 
resulting from the degradation of C-QA or C-IA. It is rather formed by the interaction 
between the substrate and the medium (see 3.2 and 3.3). 
In all fermentations, the concentrations of the metabolites were generally low, and the 
initial substrates C-QA and C-IA were nearly not detectable even at the beginning of 
the fermentations. Taking the ‘control samples II’ into account, where the substrate 
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was co-incubated with the media, the low concentrations are related to the fact that 
the substrate already interacts with the medium or is degraded due to the 
fermentation conditions. Substrate concentration in the control samples and 
fermentation samples were very similar. As a result, the metabolites can only occur in 
lower concentration as well. Apart from that, the extraction efficiency/recovery of the 
metabolites with ethyl acetate depends on its solubility. As C-QA and C-IA are quite 
hydrophilic, it is assumed that the substrates still remain in the aqueous medium (the 
fermentation mixture) to a certain extent and were not completely extracted with ethyl 
acetate. As already mentioned under 2.5, this extraction method was a compromise, 
as the different compounds represent a broad polarity and solubility range. For every 
metabolite, the recovery rates were determined in previous studies (data not shown), 
so it can be guaranteed that the formation of further metabolites in significant 
concentrations would have been detected as well.   
Microbiota analysis did not reveal major differences in composition after 48 hours 
incubation in the presence of C-QA or I-CA in comparison to the no-substrate control. 
The analysis performed here targeted the major bacterial groups within the 
microbiota. However, it cannot be excluded that changes may have occurred for less 
abundant groups or at a lower phylogenetic scale. All media contained 
carbohydrates, casein hydrolysate and yeast extract to ensure that the bacteria had 
an appropriate energy source available, thus microbiota changes were mainly driven 
by the growth substrates present. The absence of major differences between 
incubations indicates that the phenolic acids studied here had no major inhibitory 
effects on the microbiota. In contrast, Mills et al. (2015) have noticed changes in 
some bacterial groups such as Bifidobacterium spp and the C. coccoides – E. rectale 
group when fermenting C-QA. 
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Figure 6 shows schematically the microbial degradation of C-IA based on the in vitro 
data obtained in the present study. Studies on the bioavailability of C-QA compared 
to CA showed that the absorption of the metabolites of C-QA mainly takes place in 
the colon after C-QA is degraded by the microbiota, whereas CA is to some extent 
already absorbed in the upper intestinal tract (Olthof, Hollman, & Katan, 2001; 
Tomas-Barberan et al., 2014). Due to the similar chemical structures of C-QA to C-
IA, it was assumed that C-IA has also a very low absorption rate in the small intestine 
and fermentation in the colon is much more relevant than absorption of the initial, 
intact compound. The first step of degradation may involve esterases of microbial 
origin that cleave the ester bond of C-IA. In a study described by Couteau, 
McCartney, Gibson, Williamson, and Faulds (2001), some bacterial species being 
responsible for the esterolysis of conjugated hydroxycinnamic acids have been 
identified. The results showed that selected strains of Escherichia coli, 
Bifidobacterium lactis, and Lactobacillus gasseri have esterase activity with the 
potential to cleave C-QA and ethyl ferulate. Furthermore, Couteau et al. (2001) also 
described that CA was not further degraded by E. coli, B. lactis, and L. gasseri after 
the hydrolysis of C-QA. Those results underlined the hypothesis of Peppercorn and 
Goldman (1971), who demonstrated that twelve strains of human gut bacteria were 
not able to carry out more than one step in the degradation pathway of CA. 
Therefore, the following degradation steps observed in the present study – reduction 
of the double bond and further dehydroxylation – are probably conducted by further 
microorganisms (present in the fecal sample). It is also possible that cross feeding 
occurs whereby one strain gives good growth on a primary substrate, which is 
partially degraded to a product that is a secondary substrate for another strain; 
therefore, the composition of the microbiota might be influenced to a certain extent 
(Pfeiffer & Bonhoeffer, 2004). 
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Even though the metabolite CA was not identified in every fermentation, it can be 
hypothesized that the degradation of both substrates goes via the formation of CA. It 
seems that CA is an intermediary metabolite, which is further degraded rapidly to 3,4-
DHPPA by a reduction of the double bond. In the studies described by Booth and 
Williams (1963a, 1963b), the reduction of the double bond of CA by intestinal 
microbiota of different animal species was described for the first time and 3,4-
DHPPA, 3-HPPA, and m-coumaric acid were detected as metabolites. This reduction 
was confirmed by Scheline (1968) and described as being a general reaction for 
cinnamic acid derivatives when incubating with rat cecal contents (Soleim & Scheline, 
1972). In contrast to the study described by Booth and Williams (1963a), the 
metabolite m-coumaric acid was not identified in the work of Scheline (1968). The 
results of the latter study correspond to the results of the present study. Scheline 
(1968) explained that the capacity of the cecal microorganisms to reduce the double 
bond greatly exceeds the capacity to dehydroxylate the aromatic ring primarily.  
In 1966, a strain of Pseudomonas sp. was isolated from rat feces being able to 
dehydroxylate CA to 3-HPPA and m-coumaric acid (Perez-Silva, Rodriguez, & Perez-
Silva, 1966). With every degradation step, the metabolites become more lipophilic 
allowing absorption via passive diffusion into the enterocytes of the colon. Once the 
metabolites are absorbed, they enter the blood stream, reach the portal vein and the 
liver where they become conjugated. Here, the metabolites undergo several 
transformations until they are secreted with the urine or the bile (Marin et al., 2015). 
Metabolites which are not absorbed or re-absorbed will be excreted with the feces 
(Marin et al., 2015).  
In vivo studies on the metabolism of C-QA or CA showed the formation of benzoic 
acid or its conjugates such as hippuric acid (Gonthier et al., 2003; Olthof, Hollman, 
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Buijsman, van Amelsvoort, & Katan, 2003). Benzoic acid is partly formed in vivo in 
the liver from 3-PPA by shortening the side chain via β-oxidation (Gonthier et al., 
2003). Therefore, 3-PPA is assigned to be a precursor metabolite for benzoic acid 
(Gonthier et al., 2006). It is not clear whether 3-PPA is formed from the 
microorganisms within a longer fermentation period or if the conversion from 3-HPPA 
to 3-PPA results from the mammalian organism. For that, it might be possible that 
even though 3-PPA was not identified as a main metabolite in the in vitro 
fermentations and it was rather formed by the interaction of the substrate with the 
medium, it would have been formed by a dehydroxylation of 3-HPPA or 4-HPPA 
during a longer fermentation time.  
In conclusion, the substrates C-QA and C-IA were degraded in all in vitro 
fermentations performed in the present study. The main reactions were the cleavage 
of the ester bond, followed by the reduction of the double bond and dehydroxylation 
in C3- or C4- position of the aromatic ring. By comparing the degradation of C-QA 
with C-IA, very similar metabolite formations and time courses were determined.  
With regard to the consumption of amaranth, C-IA can be metabolized by the human 
gut microbiota. Furthermore, it is assumed that these metabolites can be also 
absorbed via the colon and undergo further hepatic metabolism. Despite the fact that 
C-QA occurs more ubiquitous, amaranth is a relevant source of other esterified 
phenolic compounds. 
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Figure captions 
Figure 1. Chemical structure of chlorogenic acid (A) and caffeoylisocitric acid (B). 
Figure 2. Mass fragmentation pattern of caffeoylisocitric (m/z 353.05008) acid 
obtained by qTOF analysis. 
Figure 3. Metabolite formation of chlorogenic acid (C-QA) for three independent in 
vitro fermentations with different donors (A, B, and C). Each data point represents the 
mean and standard deviation of triplicates. 
Figure 4. Metabolite formation of caffeoylisocitric acid (C-IA) for three independent in 
vitro fermentations with different donors (A, B, and C). Each data point represents the 
mean and standard deviation of triplicates. 
Figure 5. Bacterial composition of the initial fecal samples and fecal incubations (48 
h) from donor A, B, and C, in ‘control samples I’ and in the presence of chlorogenic 
acid (C-QA) or caffeoylisocitric acid (C-IA). Data represents the mean and standard 
deviation of triplicates. 
Figure 6. Schematic microbial degradation pathway of caffeoylisocitric acid (C-IA) in 
the colon. (CA, caffeic acid; 3,4-DHPPA, 3-(3,4-dihydroxyphenyl)propionic acid; 3-
HPPA; 3-(3-hydroxyphenyl)propionic acid; 4-HPPA, 3-(4-hydroxyphenyl)propionic 
acid; 3-PPA, 3-phenylpropionic acid). 
* Metabolites that are not absorbed via the colon will be excreted with the feces. 
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Table 1: Quantitative PCR primers used in this study. 
Target Name Sequence 
Primer annealing 
temp (°C) 
Reference 
Universal 
UniF GTGSTGCAYGGYYGTCGTCA 
60 Fuller et al. (2007) 
UniR ACGTCRTCCMCNCCTTCCTC 
Bifidobacterium spp. 
BifF TCGCGTCYGGTGTGAAAG 
60 Fuller et al. (2007) 
g-Bifid-R GGTGTTCTTCCCGATATCTACA 
Bacteroidetes 
Bac303F GAAGGTCCCCCACATTG 
60 
Ramirez-Farias et al. 
(2009) Bfr-Fmrev CGCKACTTGGCTGGTTCAG 
Ruminococcaceae 
sg-Clept-F GCACAAGCAGTGGAGT 
60 
Matsuki et al. (2004), 
modified1 
sg-Clept-Fm2 GCACAAGCGGTGGATT 
sg-Clept-R3 CTTCCTCCGTTTTGTCAA 
Lachnospiraceae 
Erec482F CGGTACCTGACT AGAAGC 
60 
Ramirez-Farias et al. 
(2009) Erec870R AGTTTYATTCTTGCGAACG 
Faecalibacterium prausnitzii 
FPR-2F GGAGGAAGAAGGTCTTCGG 
60 
Ramirez-Farias et al. 
(2009) Fprau645R AATTCCGCCTACCTCTGCACT 
Blautia spp. 
BlautiaF2 CGCGTGAAGGAAGAAGTATC 
63 this study2 
BlautiaR2 GAGCCTCAACGTCAGTTACC 
Roseburia spp. & E. rectale 
RrecF GCGGTRCGGCAAGTCTGA 
63 
Ramirez-Farias et al. 
(2009) Rrec630mR CCTCCGACACTCTAGTMCGAC 
 
1Equal amounts of both forward primers were used to improve coverage of the Ruminococcaceae family with a total concentration of 
500 nM. The assay was validated against 16S rRNA gene amplicons of 53 gut bacteria, including 12 Ruminococcaceae, which were 
the only positive species. 
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2New primers were designed as described previously (Ramirez-Farias et al., 2009) by inspection of alignments downloaded from the 
Ribosomal Database Project (RDP; Cole et al. (2009)) and by RDP Probe match analysis. Primers were validated against 16S rRNA 
gene amplicons of 44 gut bacteria, including 25 Lachnospiraceae species. Only the target group (Blautia obeum A2-162, Blautia 
hydrogenotrophica DSM 10507, Blautia producta DSM 14466, Blautia hansenii DSM 20583) was found to be positive.  
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Fig. 2  
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Fig. 3  
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Fig. 4  
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Fig. 5  
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Fig. 6  
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HIGHLIGHTS  
 Microbial degradation of caffeoylisocitric acid from amaranth was characterized 
 Metabolites of caffeoylisocitric acid and chlorogenic acid fermentations are very similar 
 Composition of the microbiota was not affected 
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